<- Go Home
Ibere Pharmaceuticals
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
Market Cap
$175.6M
Volume
38.9K
Cash and Equivalents
$4.5K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.75
52 Week Low
$9.74
Dividend
N/A
Price / Book Value
-30.10
Price / Earnings
28.40
Price / Tangible Book Value
-30.10
Enterprise Value
$175.8M
Enterprise Value / EBITDA
N/A
Operating Income
-$1.0M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$4.5K
Debt
$158.9K
Equity
-$5.8M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium